GB9827102D0 - New cancer treatments - Google Patents

New cancer treatments

Info

Publication number
GB9827102D0
GB9827102D0 GBGB9827102.6A GB9827102A GB9827102D0 GB 9827102 D0 GB9827102 D0 GB 9827102D0 GB 9827102 A GB9827102 A GB 9827102A GB 9827102 D0 GB9827102 D0 GB 9827102D0
Authority
GB
United Kingdom
Prior art keywords
cancer treatments
new cancer
new
treatments
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9827102.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Onyvax Ltd
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Priority to GBGB9827102.6A priority Critical patent/GB9827102D0/en
Publication of GB9827102D0 publication Critical patent/GB9827102D0/en
Priority to PCT/GB1999/004146 priority patent/WO2000033871A2/en
Priority to AU16696/00A priority patent/AU1669600A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/884—Vaccine for a specifically defined cancer prostate
GBGB9827102.6A 1998-12-10 1998-12-10 New cancer treatments Ceased GB9827102D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9827102.6A GB9827102D0 (en) 1998-12-10 1998-12-10 New cancer treatments
PCT/GB1999/004146 WO2000033871A2 (en) 1998-12-10 1999-12-09 Use of human prostate tumour cell lines in cancer treatment
AU16696/00A AU1669600A (en) 1998-12-10 1999-12-09 New cancer treatments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827102.6A GB9827102D0 (en) 1998-12-10 1998-12-10 New cancer treatments

Publications (1)

Publication Number Publication Date
GB9827102D0 true GB9827102D0 (en) 1999-02-03

Family

ID=10843924

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9827102.6A Ceased GB9827102D0 (en) 1998-12-10 1998-12-10 New cancer treatments

Country Status (3)

Country Link
AU (1) AU1669600A (en)
GB (1) GB9827102D0 (en)
WO (1) WO2000033871A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176022B2 (en) 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
US20050019336A1 (en) * 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
WO2005023328A2 (en) * 2003-08-26 2005-03-17 Becton Dickinson And Company Methods for intradermal delivery of therapeutics agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245099C (en) * 1996-02-02 2007-01-09 Suzanne L. Topalian Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer

Also Published As

Publication number Publication date
AU1669600A (en) 2000-06-26
WO2000033871A2 (en) 2000-06-15
WO2000033871A3 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
HUP0104857A3 (en) New cancer treatments
GB9804885D0 (en) Therapeutic combination
GB9800942D0 (en) Well treatment
GB9812038D0 (en) Therapeutic compound
GB9805877D0 (en) Cancer
GB9816556D0 (en) Therapy
AU1710600A (en) Enhanced radiation therapy
GB9703633D0 (en) Cancer therapy
GB9803447D0 (en) Cancer diagnosis
GB9827102D0 (en) New cancer treatments
GB9819999D0 (en) Treatment of cancer
GB9804361D0 (en) Cancer treatment
GB9903035D0 (en) Treating cancer
GB2334579B (en) Treating cancer
AU2453399A (en) Bone cancer therapy
AU4598100A (en) Treating cancer
GB9818524D0 (en) Inorgasmia treatment
GB9815497D0 (en) Treatment
GB9818023D0 (en) Cancer treatment
GB9820000D0 (en) Cancer treatment
GB9812151D0 (en) Treating cancer
GB9806039D0 (en) Therapy
GB9804050D0 (en) Cancer
GB9828550D0 (en) Treatment
GB9802420D0 (en) Skin cancer alleviator

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)